Company: SNWV
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001628280-25-038937
Chunk: 6

Company: SANUWAVE Health, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 2
Chunk 6
---
 due to increased headcount expenses of $0.7 million and non-cash charges for stock-based compensation of $0.4 million; partially offset by decreases in Travel & Entertainment expenses of $0.1 million and Service Contracts of $0.1 million.

Research and Development

Research and development expenses for each of the three months ended June 30, 2025, and June 30, 2024, were $0.2 million. The research and development costs in the three months ended June 30, 2025, remained approximately consistent with the costs in the same period of 2024.

Research and development expenses for each of the six months ended June 30, 2025, and June 30, 2024, were $0.4 million. The research and development costs in the six months ended June 30, 2025, remained approximately consistent with the costs in the same period of 2024.

26

Other (Expense) Income, net

Other (expense) income, net consists of the following:

Three Months Ended June 30,ChangeSix Months Ended June 30,Change20252024$%20252024$%Interest expense$(1,874)$(3,783)$1,909 50%$(3,726)$(7,343)$3,617 49%Change in fair value of derivative liabilities990 3,717 (2,727)73%(3,911)1,216 (5,127)422%Gain on extinguishment of debt- 5,310 (5,310)-%- 5,205 (5,205)-%Other expense(27)(685)658 96%(28)(787)759 96%Other income89 10 79 790%181 2,800 (2,619)(94%)Other (expense) income, net$(822)$4,569 $(5,391)118%$(7,484)$1,091 $(8,575)786%

Other (expense) income, net decreased by $5.4 million to other expense of $0.8 million for the three months ended June 30, 2025, as compared to other income of $4.6 million for the same period of 2024. The decrease was primarily driven by a decrease in gain on extinguishment of debt of $5.3 million and a decrease from the change in the fair value of derivative liabilities of $2.